Pages that link to "Q34650833"
Jump to navigation
Jump to search
The following pages link to Corticotropin-releasing hormone induces skin vascular permeability through a neurotensin-dependent process (Q34650833):
Displaying 47 items.
- Atopic diseases and inflammation of the brain in the pathogenesis of autism spectrum disorders (Q26746354) (← links)
- Genitourinary mast cells and survival (Q26774258) (← links)
- Brain "fog," inflammation and obesity: key aspects of neuropsychiatric disorders improved by luteolin (Q26802187) (← links)
- Emerging role of mast cells and macrophages in cardiovascular and metabolic diseases (Q26825467) (← links)
- Do mast cells link obesity and asthma? (Q27001152) (← links)
- Stress triggers coronary mast cells leading to cardiac events (Q27022598) (← links)
- Quercetin is more effective than cromolyn in blocking human mast cell cytokine release and inhibits contact dermatitis and photosensitivity in humans (Q28481712) (← links)
- Role of Corticotropin-releasing Factor in Gastrointestinal Permeability. (Q30421083) (← links)
- Physiology, pharmacology, and therapeutic relevance of urocortins in mammals: ancient CRF paralogs (Q30487401) (← links)
- Mitochondrial uncoupling protein 2 inhibits mast cell activation and reduces histamine content (Q34077923) (← links)
- Neurotensin is increased in serum of young children with autistic disorder (Q34114124) (← links)
- Mast cell activation and autism (Q34156983) (← links)
- Brief Report: “Allergic Symptoms” in Children with Autism Spectrum Disorders. More than Meets the Eye? (Q34157800) (← links)
- Key role of CRF in the skin stress response system (Q34363640) (← links)
- Neurotensin and CRH interactions augment human mast cell activation (Q34479187) (← links)
- Isoflavones inhibit poly(I:C)-induced serum, brain, and skin inflammatory mediators - relevance to chronic fatigue syndrome (Q34537221) (← links)
- The novel flavone tetramethoxyluteolin is a potent inhibitor of human mast cells (Q35305446) (← links)
- Increased serum baseline tryptase levels and extensive skin involvement are predictors for the severity of mast cell activation episodes in children with mastocytosis (Q35951578) (← links)
- Fibromyalgia syndrome in need of effective treatments (Q36186172) (← links)
- Corticotropin-releasing hormone and extracellular mitochondria augment IgE-stimulated human mast-cell vascular endothelial growth factor release, which is inhibited by luteolin (Q36298946) (← links)
- Serum neurotensin (NT) is increased in psoriasis and NT induces vascular endothelial growth factor release from human mast cells (Q36401164) (← links)
- Neuropeptides CRH, SP, HK-1, and Inflammatory Cytokines IL-6 and TNF Are Increased in Serum of Patients with Fibromyalgia Syndrome, Implicating Mast Cells (Q36618726) (← links)
- Focal brain inflammation and autism (Q36766675) (← links)
- Inflammation and neuropeptides: the connection in diabetic wound healing (Q37002385) (← links)
- Sphingosine-1-phosphate can promote mast cell hyper-reactivity through regulation of contactin-4 expression (Q37238305) (← links)
- Neurotensin stimulates sortilin and mTOR in human microglia inhibitable by methoxyluteolin, a potential therapeutic target for autism (Q37417949) (← links)
- Elevated serum neurotensin and CRH levels in children with autistic spectrum disorders and tail-chasing Bull Terriers with a phenotype similar to autism. (Q37537023) (← links)
- Atopic dermatitis in children: management of pruritus (Q38052176) (← links)
- Chronic pruritus associated with dermatologic disease in infancy and childhood: update from an interdisciplinary group of dermatologists and pediatricians (Q38131810) (← links)
- Stress-related skin disorders (Q38883601) (← links)
- Neuroendocrinology of mast cells: Challenges and controversies (Q39091869) (← links)
- Circulating Proneurotensin Concentrations and Cardiovascular Disease Events in the Community: The Framingham Heart Study (Q40696540) (← links)
- Children with autism spectrum disorders, who improved with a luteolin-containing dietary formulation, show reduced serum levels of TNF and IL-6. (Q41270272) (← links)
- A role for type 1alpha corticotropin-releasing hormone receptors in mediating local changes in chronically inflamed tissue (Q41812215) (← links)
- In Silico Modeling of Liver Metabolism in a Human Disease Reveals a Key Enzyme for Histidine and Histamine Homeostasis (Q42096046) (← links)
- Neurotensin decreases the proinflammatory status of human skin fibroblasts and increases epidermal growth factor expression (Q42837357) (← links)
- On the role of the corticotropin-releasing hormone signalling system in the aetiology of inflammatory skin disorders (Q43171063) (← links)
- Neuronal plasticity of the "brain-skin connection": stress-triggered up-regulation of neuropeptides in dorsal root ganglia and skin via nerve growth factor-dependent pathways (Q48101321) (← links)
- TNF stimulates IL-6, CXCL8 and VEGF secretion from human keratinocytes via activation of mTOR, inhibited by tetramethoxyluteolin (Q48362769) (← links)
- Increased number of non-degranulated mast cells in pancreatic ductal adenocarcinoma but not in acute pancreatitis (Q50426404) (← links)
- Corticotropin-Releasing Factor Regulates TLR4 Expression in the Colon and Protects Mice From Colitis (Q51901426) (← links)
- Neurotensin serum levels and skin gene expression are increased in atopic dermatitis. (Q54243580) (← links)
- Sex differences in the effects of early life stress exposure on mast cells in the developing rat brain (Q91759094) (← links)
- Mast Cells, Stress, Fear and Autism Spectrum Disorder (Q92177636) (← links)
- Mast Cells May Regulate The Anti-Inflammatory Activity of IL-37 (Q92290029) (← links)
- Recent advances in our understanding of mast cell activation - or should it be mast cell mediator disorders? (Q92447847) (← links)
- Mast Cells, Neuroinflammation and Pain in Fibromyalgia Syndrome (Q92711498) (← links)